Concurrent radiation and chemotherapy is a standard treatment of patients with cervical
cancer in FIGO stages IB2-IVA. Chemotherapy given in the same time as irradiation …

PURPOSE: To investigate the expression of cyclooxygenase (COX-2) and its association
with clinicopathologic parameters and clinical outcome in patients with cervical cancer …

OBJECTIVE: Previous data demonstrate an association between cyclooxygenase activity
and development of cervical cancer. This review investigates the role of cyclooxygenase-2 …

Published data on the prognostic value of cyclooxygenase‐2 (COX‐2) overexpression in
cervical cancer are conflicting and heterogeneous. We performed a meta‐analysis to more …

Purpose: The purpose of this study was to examine the relationship between overall survival
and prognostic factors in carcinoma of the cervix treated with radiation therapy. A …

Purpose: Cyclooxygenase-2 (COX-2) plays a pivotal role in regulation of radiation-induced
apoptosis. The aim of this study was to analyze the relationship between COX-2 expression …

Cervical carcinoma ranks fourth among the leading causes of cancer worldwide, after
carcinoma of breast, colorectal carcinoma and lung carcinoma. In developing countries like …

BACKGROUND The objective of this study was to determine whether cyclooxygenase‐2
(COX‐2) overexpression was an indicator of prognosis in patients with International …

Objective: The purpose of the present study was to determine the differential expression
pattern of cyclooxygenase-2 (COX-2) in patients of carcinoma of uterine cervix and its …

Purpose: To investigate whether cyclooxygenase-2 (COX-2) could be a marker of clinical
outcome in cervical cancer patients undergoing concomitant chemoradiation plus surgery …